Human mesenchymal stromal cells exert HGF dependent cytoprotective effects in a human relevant pre-clinical model of COPD

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kennelly, Helen ^a   Mahon, Bernard P ^a   English, Karen ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HGF PROTEIN, HUMAN; PANCREATIC ELASTASE; SCATTER FACTOR;

ANIMAL; APOPTOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE MODEL; EMPHYSEMA; FIBROSIS; GENETICS; HUMAN; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; EMPHYSEMA; FIBROSIS; HEPATOCYTE GROWTH FACTOR; HUMANS; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE, INBRED NOD; PANCREATIC ELASTASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 85002522535     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38207     Document Type: Article

References (56)

1. Lopez, a. D. Chronic obstructive pulmonary disease: current burden and future projections. Eur. Respir. J. 27, 397-412 (2006).
2. Chung, K. F., Adcock, I. M. Multifaceted mechanisms in COPD: inflammation, immunity, tissue repair and destruction. Eur. Respir. J. 31, 1334-56 (2008).
3. Barnes, P. J., Celli, B. R. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 33, 1165-85 (2009).
4. Stockley, R. a. Neutrophils and the pathogenesis of COPD. Chest 121, 151S-155S (2002).
5. Noguera, a. et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 56, 432-437 (2001).
6. Cahill, E. F., Tobin, L. M., Carty, F., Mahon, B. P., English, K. Jagged-1 is required for the expansion of CD4+ CD25+ FoxP3+ regulatory T cells and tolerogenic dendritic cells by murine mesenchymal stromal cells. Stem Cell Res. Ther. 6, 1-13 (2015).
7. Noone, C., Kihm, A., English, K., O'Dea, S., Mahon, B. P. IFN-Stimulated Human Umbilical-Tissue-Derived Cells Potently Suppress NK Activation and Resist NK-Mediated Cytotoxicity In Vitro. Stem Cells Dev. 22, 3003-3014 (2013).
8. Tobin, L. M., Healy, M. E., English, K., Mahon, B. P. Human mesenchymal stem cells suppress donor CD4+ T cell proliferation and reduce pathology in a humanized mouse model of acute graft-versus-host disease. Clin. Exp. Immunol. 172, 333-348 (2013).
9. Chen, Q.-H., Liu, A.-R., Qiu, H.-B., Yang, Y. Interaction between mesenchymal stem cells and endothelial cells restores endothelial permeability via paracrine hepatocyte growth factor in vitro. Stem Cell Res. Ther. 6, 44 (2015).
10. Li, J.-W., Wu, X. Mesenchymal stem cells ameliorate LPS-induced acute lung injury through KGF promoting alveolar fluid clearance of alveolar type II cells. Eur. Rev. Med. Pharmacol. Sci. 19, 2368-2378 (2015).
11. Bai, L. et al. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 15, 862-870 (2012).
12. Nemeth, K. et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15, 42-49 (2009).
13. Bruno, S. et al. Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury. J. Am. Soc. Nephrol. 20, 1053-1067 (2009).
14. Nagaya, N. et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Hear. Circ Physiol. 287, 5-7 (2004).
15. Matthay, M. A. et al. Therapeutic Potential of Mesenchymal Stem Cells for Severe Acute Lung Injury. Chest 138, 965-972 (2010).
16. Wei, X. et al. Mesenchymal stem cells : a new trend for cell therapy. Nat. Publ. Gr. 34, 747-754 (2013).
17. Antunes, M. A., Laffey, J. G., Pelosi, P., Rocco, P. R. M. Mesenchymal stem cell trials for pulmonary diseases. J. Cell. Biochem. 115, 1023-1032 (2014).
18. Kavanagh, H., Mahon, B. P. Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy 66, 523-31 (2011).
19. Yew, T.-L. et al. Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation. Cell Transplant. 20, 693-706 (2011).
20. Curley, G. F. et al. Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 67, 496-501 (2012).
21. Bai, L., Lennon, D. P., Caplan, A. I., Dechant, A., Hecker, J. Hepatocyte growth factor mediates MSCs stimulated functional recovery in animal models of MS. Nat. Neurosci. 15, 862-870 (2012).
22. Murphy, J. M. et al. Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis Rheum. 46, 704-713 (2002).
23. Hubner, R.-H. et al. Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 44, 507-511, 514-517 (2008).
24. Takata, F. et al. Elevated permeability of the blood-brain barrier in mice intratracheally administered porcine pancreatic elastase. J. Pharmacol. Sci. 129, 78-81 (2015).
25. Hodge, S., Hodge, G., Holmes, M., Reynolds, P. N. Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur. Respir. J. 25, 447-454 (2005).
26. Imai, K., Mercer, B. A., Schulman, L. L., Sonett, J. R., D'Armiento, J. M. Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur. Respir. J. 25, 250-258 (2005).
27. Salazar, L. M., Herrera, A. M. Fibrotic response of tissue remodeling in COPD. Lung 189, 101-109 (2011).
28. Hegab, A. E. et al. Intranasal HGF Administration Ameliorates the Physiologic and Morphologic Changes in Lung Emphysema. Mol. Ther. 16, 1417-1426 (2008).
29. Calvi, C. et al. Hepatocyte Growth Factor, a Determinant of Airspace Homeostasis in the Murine Lung. PLoS Genet. 9, e1003228 (2013).
30. Antunes, M. a. et al. Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. Respir. Res. 15, 118 (2014).
31. Gogebakan, B. et al. The role of bronchial epithelial cell apoptosis in the pathogenesis of COPD. Mol. Biol. Rep. 41, 5321-5327 (2014).
32. Siganaki, M. et al. Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients. Respir. Res. 11, 46 (2010).
33. Cai, S. et al. Activation of Wnt/-catenin signalling promotes mesenchymal stem cells to repair injured alveolar epithelium induced by lipopolysaccharide in mice. Stem Cell Res. Ther. 6, 65 (2015).
34. Akram, K. M., Samad, S., Spiteri, M. a & Forsyth, N. R. Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms. Respir. Res. 14, 9 (2013).
35. Cruz, F. F. et al. Protective effects of bone marrow mononuclear cell therapy on lung and heart in an elastase-induced emphysema model. Respir. Physiol. Neurobiol. 182, 26-36 (2012).
36. Luthje, L. et al. Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model. Respir. Res. 10, 7 (2009).
37. Huh, J. W. et al. Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 301, L255-66 (2011).
38. Guan, X.-J. et al. Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors. J. Cell. Biochem. 114, 323-335 (2013).
39. Gu, W. et al. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways. Sci. Rep. 5, 8733 (2015).
40. Shigemura, N. et al. Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema. Am. J. Transplant 6, 2592-2600 (2006).
41. Li, Y. et al. Therapeutic effects of amniotic fluid-derived mesenchymal stromal cells on lung injury in rats with emphysema. Respir. Res. 15, 120 (2014).
42. Kim, Y.-S. et al. Tracking Intravenous Adipose-Derived Mesenchymal Stem Cells in a Model of Elastase-Induced Emphysema. Tuberc. Respir. Dis. (Seoul). 77, 116-123 (2014).
43. Peron, J. P. S. et al. Human Tubal-Derived Mesenchymal Stromal Cells Associated with Low Level Laser Therapy Significantly Reduces Cigarette Smoke-Induced COPD in C57BL/6 mice. PLoS One 10, e0136942 (2015).
44. Li, X. et al. Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage. Am. J. Respir. Cell Mol. Biol. 51, 455-465 (2014).
45. Tibboel, J., Keijzer, R., Reiss, I., de Jongste, J. C., Post, M. Intravenous and intratracheal mesenchymal stromal cell injection in a mouse model of pulmonary emphysema. COPD 11, 310-318 (2014).
46. Weiss, D. J., Casaburi, R., Flannery, R., LeRoux-Williams, M., Tashkin, D. P. A Placebo-Controlled, Randomized Trial of Mesenchymal Stem Cells in COPD. CHEST J. 143, 1590 (2013).
47. Samsonraj, R. M. et al. Establishing Criteria for Human Mesenchymal Stem Cell Potency. Stem Cells 33, 1878-1891 (2015).
48. Katsha, A. M. et al. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol. Ther. 19, 196-203 (2011).
49. Bhowmik, A. et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. 114-120 doi: 10. 1136/thorax. 55. 2. 114 (2000).
50. Giannopoulou, M., Dai, C., Tan, X., Wen, X., Michalopoulos, G. K. Hepatocyte Growth Factor Exerts Its Anti-Inflammatory Action by Disrupting Nuclear Factor-B Signaling. 173, 30-41 (2008).
51. Coudriet, G. M., He, J., Trucco, M., Mars, W. M., Piganelli, J. D. Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases. PLoS One 5, e15384 (2010).
52. Molnar, C. et al. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist. Eur. Cytokine Netw. 15, 303-311 (2004).
53. Yokohori, N., Aoshiba, K., Nagai, A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest 125, 626-632 (2004).
54. Hou, H. H. et al. Elastase induced lung epithelial cell apoptosis and emphysema through placenta growth factor. Cell Death Dis. 4, e793 (2013).
55. Lucey, E. C., Goldstein, R. H., Stone, P. J., Snider, G. L. Remodeling of alveolar walls after elastase treatment of hamsters. Results of elastin and collagen mRNA in situ hybridization. Am. J. Respir. Crit. Care Med. 158, 555-564 (1998).
56. Cahill, E. F., Kennelly, H., Carty, F., Mahon, B. P., English, K. Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis. Stem Cells Transl. Med. 5, 1307-1318 (2016).